Xeris Biopharma Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Xeris Biopharma Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Xeris Biopharma Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $22.8M, a 2.77% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $22.8M -$649K -2.77% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $22.9M -$768K -3.25% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $23M +$19.1M +493% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $23.2M +$19.2M +481% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $23.4M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $23.6M Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.89M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.99M +$3.99M Dec 31, 2022 10-K 2024-03-06
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.